Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
Facts & Figures News Career Baxter Worldwide
 
Press Releases

  CSC Wins $19.6 Million Contract for Advanced Development of Chemical Nerve Agent Treatment

CSC’s DVC Teams with Baxter Healthcare Corporation to Produce Plasma-Derived Human Butyrylcholinesterase EL SEGUNDO, Calif. and DEERFIELD, ...

Date: 2005/04/13 » read more

  Baxter Satellite Symposium

Meningococcal Disease - PREVALENCE AND PREVENTION.
4th World Congress of The World Society for Pediatric Infectious Diseases Wars ...

Date: 2005/01/01 » read more

  Baxter Satellite Symposium

2nd European Influenza Conference St.Julians, Malta September 11-14, 2005

Date: 2005/01/01 » read more

  Baxter Suspends Enrollment in European Clinical Trial for PreFluCel

DEERFIELD, Ill., December 9, 2004 – Baxter International Inc. announced today that it has voluntarily suspended enrollment in the Phase II/III clinica ...

Date: 2004/12/09 » read more

  BAXTER AWARDED CONTRACT FROM NIH FOR DEVELOPMENT OF SARS VACCINE

Deerfield, Ill., September 29, 2003 – Baxter Healthcare Corporation announced today that it has been awarded a $10 million contract by the National In ...

Date: 2003/09/29 » read more

  BAXTER TO LAUNCH VACCINE IN GERMANY TO PROTECT AGAINST TICK-BORNE ENCEPHALITIS

Deerfield, IL, June 19, 2002 -- Baxter International Inc. announced today that a subsidiary's tick-borne encephalitis vaccine, FSME-IMMUN 0.5 ml, rece ...

Date: 2002/06/19 » read more

  BAXTER ANNOUNCES THE LOCATIONS OF TWO NEW,

Company Receives Regulatory Approval in the Netherlands for InfluJect Influenza Vaccine DEERFIELD, Ill., March 11, 2002 -- Baxter Interna ...

Date: 2002/03/11 » read more

  BAXTER CONFIRMS ROLE IN SMALLPOX VACCINE PRODUCTION

Deerfield, Ill., November 28, 2001 -- Baxter Healthcare Corporation confirmed today that it will participate in the production of appr ...

Date: 2001/11/28 » read more

  BAXTER AND PEPTIDE THERAPEUTICS ENTER INTO STRATEGIC ALLIANCE TO ADVANCE VACCINE PRODUCT DEVELOPMENT

GLENDALE, Calif., September 20, 2000 - Baxter Healthcare Corporation announced today that it has agreed to enter into a strategic alliance with ...

Date: 2001/09/20 » read more

  BAXTER HEALTHCARE CORPORATION RECEIVES AWARD FOR NEISVAC-C FROM TECHNOLOGY COUNCIL OF MARYLAND

Biotechnology Product of the Year for Prevention of Group C Meningococcal Meningitis Columbia, MD, April 20, 2001 - Baxter Healthcare Corp ...

Date: 2001/04/20 » read more

 
« previous   1 | 2 | 3   next »
 
 
  » find


 

Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
» read more

Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more

Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,